The development and evaluation of an individualised information package for patients with rectal cancer
ISRCTN | ISRCTN42959693 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN42959693 |
Secondary identifying numbers | N/A |
- Submission date
- 22/11/2008
- Registration date
- 30/01/2009
- Last edited
- 27/11/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Vivien Coates
Scientific
Scientific
Altnagelvin Hospital
Glenshane Road
Londonderry
BT47 6SB
United Kingdom
Phone | +44 (0)28 71345171 x 3037 |
---|---|
Viv.Coates@westerntrust.hscni.net |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Other |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | The development and evaluation of an individualised information package for patients with rectal cancer: a randomised controlled trial |
Study objectives | Does a tailored information package for people with rectal cancer affect anxiety, length of consultation and number of follow-up consultations with the Stoma Care Nurse Specialist (SCNS)? Does a tailored information package help to prepare patients for survivorship following a diagnosis of rectal cancer? |
Ethics approval(s) | Office for Research Ethics Committees in Northern Ireland (ORECNI), approved on 09/07/2008 (ref: 08/NIR01/36) |
Health condition(s) or problem(s) studied | Cancer of the rectum |
Intervention | The intervention group will receive a series of leaflets from the newly designed information pack depending on their condition, treatment plan and choice of information. To assist people with literacy difficulties and to ensure that the leaflets' content is understood the SCNS will go through a "guided tour" of the information leaflets with each patient in the intervention group. The intervention group will also receive the usual care that they would receive at any appointment with the Nurse Specialist. The nurse will discuss their condition, treatment options and concerns. The patients will also have an opportunity to ask questions. The control group will receive usual care and will receive the generic colorectal cancer leaflets currently used in usual care. The length of the consultations for both the intervention and control groups will be recorded. The total duration of the study and follow-up is approximately seven months with data collection at time 1 (at diagnosis) time 2 (just before discharge from hospital after surgery) and time 3 (six months after time 2). |
Intervention type | Other |
Primary outcome measure | 1. Satisfaction with information, assessed using Patient Satisfaction with Cancer Treatment Education (PS-Ca-TE) at T1, T2 and T3 2. Anxiety will be measured using the Hospital Anxiety and Depression Scale at T1, T2 and T3 3. Health behavioural style, assessed by the Monitor-Blunter style scale at T1 only 4. Preparation for Survivorship will be measured using Reintegration to Normal Living Index at T1, T2 and T3 Length of consultation with the Stoma Care Nurse Specialist and number of follow-up appointments with the Stoma Care Nurse Specialist will be recorded by the Stoma Care Nurse Specialist for the duration of the study for each participant. Timepoints for data collection: T1: At diagnosis T2: Just before discharge from hospital after surgery T3: Six months after T2 |
Secondary outcome measures | No secondary outcome measures |
Overall study start date | 01/12/2008 |
Completion date | 31/08/2010 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Other |
Sex | Both |
Target number of participants | 94 |
Key inclusion criteria | 1. Both males and females, no age limits 2. Patients with a new diagnosis of rectal cancer |
Key exclusion criteria | Patients at an advanced stage of illness who are under the care of the palliative care team or who are considered to have a prognosis of less than six months. |
Date of first enrolment | 01/12/2008 |
Date of final enrolment | 31/08/2010 |
Locations
Countries of recruitment
- Northern Ireland
- United Kingdom
Study participating centre
Altnagelvin Hospital
Londonderry
BT47 6SB
United Kingdom
BT47 6SB
United Kingdom
Sponsor information
Western Health and Social Care Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
Altnagelvin Hospital
Glenshane Road
Londonderry
BT48 8RR
Northern Ireland
United Kingdom
Phone | +44 (0)28 71345171 |
---|---|
Gloria.OConnor@westerntrust.hscni.net | |
Website | http://www.westerntrust.hscni.net/ |
https://ror.org/00sb42p15 |
Funders
Funder type
Government
Northern Ireland Health and Social Services Central Services Agency, R&D Office (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/04/2014 | Yes | No |
Editorial Notes
27/11/2015: Publication reference added.